News
2d
The Cool Down on MSNScientists uncover disturbing new threat increasing the risk of serious illness for millions: 'The impacts ... cannot be overstated'When people think about increasing temperatures, they often consider the effects on people in terms of natural disasters or ...
Urolithiasis is a highly prevalent and multifactorial disease, representing the most common urological condition globally.
THIS YEAR the Spanish capital, Madrid, provided the backdrop for Europe’s biggest urological event, the 40th Annual European ...
Oncologic Outcomes in Patients Undergoing Radical Cystectomy for non–muscle-invasive bladder cancer (NMIBC) Following BCG Therapy Failure. Dr. Oberneder highlighted that the U.S. FDA has approved ...
Dr. Ben-David began his presentation by highlighting that tumor-informed circulating tumor DNA (ctDNA) has emerged as a novel prognostic biomarker in bladder cancer. His team sought to evaluate ...
The key takeaways are that prostate cancer misinformation is widespread across online platforms and spans many different ...
Lead investigational program, NDV-01, for High-Grade Non-Muscle Invasive Bladder Cancer, is being evaluated in a Phase 2 study. In addition, preparations are underway to advance sepranolone, a Phase ...
Endo has launched a Spatial Computing Injection Simulator for Peyronie’s disease that works with the Apple Vision Pro. The ...
At AUA 2025, experts will present on novel bladder cancer therapies, advanced renal cell carcinoma comparisons, frailty in ...
Johnson & Johnson announced that new data from its oncology pipeline will be presented at the American Urological Association 2025 Annual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results